We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
CNX Resources
CNX
$4.85B
| $1.45M | 0.01% |
154,000
-201,849
| -57% | -$1.47M |
|
|
HMIN
627
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
| $1.44M | 0.01% |
40,359
+20,038
| +99% | +$693K |
|
|
KDNY
628
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.43M | 0.01% |
+22,332
| New | +$1.81M |
|
629
8x8 Inc
EGHT
$247M
| $1.42M | 0.01% |
+141,363
| New | +$1.55M |
|
630
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $1.42M | 0.01% |
+15,998
| New | +$1.31M |
|
|
MEG
631
DELISTED
Media General, Inc
MEG
| $1.42M | 0.01% |
86,773
-139,165
| -62% | -$2.24M |
|
632
ESCO Technologies
ESE
$8.49B
| $1.4M | 0.01% |
+36,018
| New | +$1.28M |
|
633
Penske Automotive Group
PAG
$14.3B
| $1.39M | 0.01% |
36,683
-33,601
| -48% | -$1.2M |
|
|
NTRI
634
DELISTED
NutriSystem, Inc.
NTRI
| $1.39M | 0.01% |
66,607
-66,416
| -50% | -$1.31M |
|
|
QGENF
635
DELISTED
QIAGEN NV
QGENF
| $1.37M | 0.01% |
61,307
+52,307
| +581% | +$1.17M |
|
636
Petrobras
PBR
$121B
| $1.36M | 0.01% |
232,878
+33,968
| +17% | +$137K |
|
637
American Eagle Outfitters
AEO
$2.85B
| $1.35M | 0.01% |
+81,147
| New | +$1.22M |
|
|
SNP
638
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $1.35M | 0.01% |
+20,697
| New | +$1.19M |
|
639
Viavi Solutions
VIAV
$9.75B
| $1.34M | 0.01% |
+195,740
| New | +$1.18M |
|
|
IMOS
640
ChipMOS TECHNOLOGIES
IMOS
$1.92B
| $1.34M | 0.01% |
+69,800
| New | +$1.34M |
|
641
Bath & Body Works
BBWI
$4.01B
| $1.33M | 0.01% |
+18,727
| New | +$1.34M |
|
642
Saic
SAIC
$5.03B
| $1.33M | 0.01% |
+24,903
| New | +$1.11M |
|
|
MORE
643
DELISTED
Monogram Residential Trust, Inc.
MORE
| $1.32M | 0.01% |
133,905
-639,718
| -83% | -$5.84M |
|
644
Kennametal
KMT
$2.68B
| $1.32M | 0.01% |
+58,551
| New | +$1.14M |
|
645
Sempra
SRE
$60.8B
| $1.32M | 0.01% |
+25,318
| New | +$1.22M |
|
646
Everest Group
EG
$15.2B
| $1.31M | 0.01% |
6,644
-9,187
| -58% | -$1.7M |
|
647
Amgen
AMGN
$203B
| $1.31M | 0.01% |
8,712
-403,588
| -98% | -$60M |
|
|
CXO
648
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.3M | 0.01% |
12,863
-83,914
| -87% | -$7.71M |
|
649
Arch Capital
ACGL
$36.1B
| $1.3M | 0.01% |
+54,750
| New | +$1.25M |
|
650
Franklin Electric
FELE
$4.67B
| $1.29M | 0.01% |
+40,025
| New | +$1.14M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.